πŸ‡ΊπŸ‡Έ FDA
Patent

US 10131653

Heterocyclic compound

granted A61KA61K31/553A61P

Quick answer

US patent 10131653 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/553, A61P, A61P25/18, A61P25/20